Compared to controls, treatment with Makena reduced the proportion of women who delivered preterm at < 37 weeks. The proportions of women delivering at < 35 and < 32 weeks also were lower among women treated with Makena. The upper bounds of the confidence intervals for the treatment difference at < 35 and < 32 weeks were close to zero. Inclusion of zero in a confidence interval would indicate the treatment difference is not statistically significant. Compared to the other gestational ages evaluated, the number of preterm births at < 32 weeks was limited.
This information should not be used to decide whether or not to take dextrose injection or any other medicine. Only the healthcare provider has the knowledge and training to decide which medicines are right for a specific patient. This information does not endorse any medicine as safe, effective, or approved for treating any patient or health condition. This is only a brief summary of general information about this medicine. It does NOT include all information about the possible uses, directions, warnings, precautions, interactions, adverse effects, or risks that may apply to dextrose injection. This information is not specific medical advice and does not replace information you receive from the healthcare provider. You must talk with the healthcare provider for complete information about the risks and benefits of using this medicine.
A scopolamine injection helps to stop smoking by blocking the nicotine receptors in the brain. The brain is the main component involved in any addiction. So, when it comes to smoking, the brain is the real enabler. The friend who offers a cigarette to a person who is trying to quit can't shoulder the bulk of the blame. This is because the brain is the organ that recognizes nicotine as something it needs to function well. So, a stop smoking injection would have to work effectively to combat and put to death the lethal relationship between the brain and nicotine.